We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go: Extended investment: Withheld
Elemental Digest is a clean-tech Agri-Food technology manufacturing business that transforms the industrial waste problem into high value-added sustainable products with impressive economic, nutritional, and environmental benefits. The company recovers valuable food extracts and creates organic 'clean' phosphate-rich fertiliser for soil and crop enhancement. These products are tested and validated by Rothamsted Research. Elemental Digest is partnered with a well-known leading international meat producer. It has qualified its final products and is ready to produce to scale. The raised funds will be used in building the fertiliser plant, developing the team, expanding markets, and research & development to qualify crop-related precision applications.
days to go: Expired investment: £1,525,240
EnXray are developing Low Energy X-ray (LEXR) technologies to sterilise equipment in commercial or research settings where low volume/high value therapeutic products, such as cancer vaccines and stem cell implants are being developed. Their aim is to reduce the need for third party providers and have the sterilisation process done on-site and on-demand with simple and safe equipment to reduce cost and save time for medical research organisations.

Pitch Rated

61%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £376,230
Ingle & Rhode has come up with ethical and traceable wedding bands and rings. The company has sold more than 6,000 rings directly to the customers. It has achieved a rating of 5-star on Trustpilot and became a finalist of 2015, 2016 and 2017 UK Jewellery Awards. They aim to offer an exceptional combination of premium quality and ethical credentials. With the proceeds, the company will boost its digital marketing campaign.

Pitch Rated

71%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £118,080
Quin is a mobile medical app that combines daily life experience with data from diabetes devices and phones and helps people decide how much insulin to take and when. They are on a mission to help people with insulin-treated diabetes make the best possible decisions through their app. The company have received a UK research and innovation grant. Apple has granted them insider access to their engineers and executives who are helping to get Quin to market, their app has a class I CE Mark, with two patents pending. With the investment, they will hire a product designer to enhance the user experience, achieve certification and compliance with new European Medical Device Regulations, develope B2B2C distribution partnerships and launch the Quin app in the UK and Europe in late 2020.

Pitch Rated

48%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £691,497
PLAYin CHOC is an innovative, premium and award-winning manufacturer of vegan organic eco-friendly toys and chocolates. Its products are allergen-free, plastic-free, 100% organic and inspire creative play. Since its launch, PLAYin CHOC has sold approximately 50,000+ units in 21 countries. Additionally, potential stockists for its products are estimated at 100,000 in the UK and 1 million globally. Now, PLAYin CHOC is planning to take its product to the market via high-end food supermarkets; independent food, confectionary and gift shops; travel retail market; direct to the consumer via subscription; and international distributors. Funds raised will be used to increase growth by securing larger and permanent premises and intensify targeted marketing at trade & consumer shows and online.
days to go: Expired investment: £278,450
At Showersave we believe in keeping things simple because simplicity is the key to any of the world’s greatest innovations. That’s why in creating Showersave we focused purely on creating a simple device that would deliver real energy saving results.
days to go: Expired investment: £78,220
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph